Robert E. Hoffman
Director · Esperion Therapeutics, Inc.
Individual
- 2025
- Jul 13, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert E. Hoffman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sheldon L. Koenig - $239K in ESPR purchases and sales in the last 12 months
- Benjamin Looker - $61K in ESPR purchases and sales in the last 12 months
- Ruben A. Garcia - $61K in FBLG purchases and sales in the last 12 months
- Benjamin Halladay - $51K in ESPR purchases and sales in the last 12 months
- Jason Davis - $29K in FBLG purchases and sales in the last 12 months
- Pete O'Heeron - $20K in FBLG purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert E. Hoffman?
Robert E. Hoffman is a corporate insider, tracked as Director of Esperion Therapeutics, Inc. (ESPR). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Robert E. Hoffman last file a Form 4?
The most recent primary Form 4 on record is dated 13 July 2026, one of 9 filings going back to 2025.
